RxDoctor Payments Data

Sangita Ghimire

Women's Health · Salem, ORNPI 1386395010

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $219, 3.0 times the $73 reported in 2022.

$547in general payments, 2019–2025

Across 32 payments — averaging $17.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$98
  • Dexcom, Inc.$69
  • Sumitomo Pharma America, Inc.$60
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$58
  • Mayne Pharma Commercial LLC$42
  • Exact Sciences$38
  • plus $183 from 7 others

What the payments were for

  • Food & beverage$547100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$547 in reported general payments places this provider in the 80th percentile of 57 women's health providers in Oregon.

See all women's health providers in Oregon

Medicare billing

Part B allowed, 2024
$4,349
Medicare patients
45
Services billed
99

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol30$1,374
Clobetasol Propionate18$506
Metronidazole11$199

Paid to pharmacies, not to this prescriber.

Other women's health in Salem

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →